Litigation Details for Louisiana Health Service and Indemnity Company v. Endo Health Solutions, Inc. (M.D. La. 2014)
✉ Email this page to a colleague
Louisiana Health Service and Indemnity Company v. Endo Health Solutions, Inc. (M.D. La. 2014)
Docket | ⤷ Try a Trial | Date Filed | 2014-11-16 |
Court | District Court, M.D. Louisiana | Date Terminated | 2014-12-22 |
Cause | 15:1 Antitrust Litigation | Assigned To | John Wheadon deGravelles |
Jury Demand | Plaintiff | Referred To | Stephen C Riedlinger |
Patents | 7,276,250 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Louisiana Health Service and Indemnity Company v. Endo Health Solutions, Inc.
Details for Louisiana Health Service and Indemnity Company v. Endo Health Solutions, Inc. (M.D. La. 2014)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2014-11-16 | 1 | ultimately issued as United States Patent No. 7,276,250 patent entitled sustained release formulations…, and ’456 patents as well as any continuations of those patents and to any pending patent applications…that is, while the patent litigation was still pending); (b) after winning the patent suit; or (c) via … normal patent infringement litigation settlements, the alleged infringer would pay the patent holder.…the expiration of the listed patents. The manufacturer may list any patents issued after the FDA approved | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |